AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bryan, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bryan, G. T.
Agricola
Right arrow Articles by Bryan, G. T.

American Journal of Clinical Nutrition, Vol 24, 841-847, Copyright © 1971 by The American Society for Clinical Nutrition, Inc.

The role of urinary tryptophan metabolites in the etiology of bladder cancer

George T. Bryan M.D., Ph.D., F.A.C.P.1

1 From The Division of Clinical Oncology, University of Wisconsin Medical School, Madison, Wisconsin 53706

Available experimental data obtained from a variety of approaches suggest that tryptophan and its urinary metabolites may be involved as one of several coordinated factors in urinary bladder carcinogenesis. When viewed with the evidence obtained from a quantitative examination of urinary tryptophan metabolites of patients with bladder carcinoma, the hypothesis that these metabolites may play a role in the genesis of human bladder cancer becomes more convincing. No substantial evidence to refute this hypothesis has been presented. However, it is equally clear that much work remains to be done to completely understand the events involved.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by The American Society for Nutrition